XPEV Stock: Price, Forecast, Financials & AI Analysis

Loading chart...

High

17.670

Open

17.530

VWAP

17.14

Vol

6.76M

Mkt Cap

16.18B

Low

16.820

Amount

115.87M

EV/EBITDA(TTM)

Total Shares

955.83M

16.78B

EV/OCF(TTM)

P/S(TTM)

1.56

XPeng Inc is a holding company mainly engaged in the design, development, manufacturing and marketing of smart electrical vehicles (EVs). The Company develops full-stack advanced driver assistance systems (ADAS) software in house and has deployed such software on mass-produced vehicles. The Company offers various models, including G9 (mid- to large-sized sport utility vehicle (SUV), P7i (sports sedan), G6 (coupe SUV), X9 (seven-seater multi-purpose vehicle (MPV)), MONA M03 (sedan) and P7+ (family sedan). The Company operates stores across China, including both stores directly operated by the Company and franchised stores. The Company also offers technical research and development services, services embedded in a sales contract, maintenance service, supercharging service.

Events Timeline

(ET)

2026-03-23

16:40:00

Trump Claims US-Iran Talks Boost Markets

2026-03-23

14:20:00

Tesla Q1 Delivery Estimate at 345K, UBS Maintains Sell Rating

2026-03-23

12:10:00

Trump Claims US-Iran Talks, Oil Prices Pull Back

News

9.5

03-23seekingalpha

XPeng Achieves First Quarterly Profit Amid AI Focus

2.0

03-23moomoo

XPENG SHARES IN HONG KONG FALL BY 5%

2.0

03-20Yahoo Finance

Consumer Stocks Decline Late Friday Afternoon

4.5

03-20NASDAQ.COM

NASDAQ 100 Pre-Market Overview

9.5

03-20seekingalpha

XPeng Reports Q4 2025 Earnings Highlights

9.5

03-20PRnewswire

XPeng Reports 2025 Financial Results: Significant Delivery Growth

6 Analyst Rating

Wall Street analysts forecast XPEV stock price to rise

4 Buy

1 Hold

1 Sell

Moderate Buy

Current: 0.000

Low

20.00

Averages

29.67

High

50.00

Current: 0.000

Low

20.00

Averages

29.67

High

50.00

Barclays

Underweight

downgrade

$17 -> $16

AI Analysis

2026-03-24

New

Reason

Barclays

Price Target

$17 -> $16

AI Analysis

2026-03-24

New

downgrade

Underweight

Reason

Barclays lowered the firm's price target on XPeng to $16 from $17 and keeps an Underweight rating on the shares post the Q4 report. The company's Q4 revenue and gross margins were inline but its Q1 outlook is "weaker," the analyst tells investors in a research note.

Macquarie

Outperform -> Neutral

downgrade

$24 -> $19

2026-03-23

Reason

Macquarie

Price Target

$24 -> $19

2026-03-23

downgrade

Outperform -> Neutral

Reason

Macquarie downgraded XPeng to Neutral from Outperform with a price target of $19, down from $24. The firm likes XPeng's physical AI "optionality" but says the company's volume growth "is no guarantee this year." The stock typically outperforms when XPeng releases a "clear hit product," but it remains too early to judge if the upcoming GX or new Mona SUV series in the second half of 2025 will have a similar impact, the analyst tells investors in a research note. Macquarie downgraded the shares after cutting XPeng's loss per share estimate to reflect the company's higher spend.

Unlock Full Analyst Thesis， Get the complete breakdown of rating reason for XPEV

Unlock Now

Valuation Metrics

The current forward P/E ratio for Xpeng Inc (XPEV.N) is 97.99, compared to its 5-year average forward P/E of 606.13. For a more detailed relative valuation and DCF analysis to assess Xpeng Inc's fair value, Click here.

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.

N/A

5Y Average PE

606.13

Current PE

97.99

Overvalued PE

3562.95

Undervalued PE

-2350.70

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.

N/A

5Y Average EV/EBITDA

26.48

Current EV/EBITDA

35.96

Overvalued EV/EBITDA

228.16

Undervalued EV/EBITDA

-175.20

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.

5Y Average PS

3.16

Current PS

1.42

Overvalued PS

5.72

Undervalued PS

0.59

Financials

AI Analysis

Annual

Quarterly

Related Community Screener

strong short term stocks

Intellectia · 19 candidates

Market Cap: >= 5.00BRsi Category: moderateList Exchange: XNYS, XNAS, XASEMoving Average Relationship: PriceAboveMA20Week Price Change Pct: >= $3.00Month Price Change Pct: >= $10.00

Ticker

Name

Market Cap$

CZR

Caesars Entertainment Inc

5.71B

HIMS

Hims & Hers Health Inc

5.65B

DELL

Dell Technologies Inc

100.48B

PBF

PBF Energy Inc

5.09B

CGON

CG Oncology Inc

5.43B

TERN

Terns Pharmaceuticals Inc

5.06B

best swing trades

Intellectia · 40 candidates

Rsi Category: moderateList Exchange: XNYS, XNAS, XASEMoving Average Relationship: PriceAboveMA20Week Price Change Pct: $5.00 - $18.00One Week Rise Prob: >= 70Monthly Average Dollar Volume: >= 1,500,000

Ticker

Name

Market Cap$

TALK

Talkspace Inc

856.44M

ACRS

Aclaris Therapeutics Inc

435.91M

PHIO

Phio Pharmaceuticals Corp

14.64M

WTI

W&T Offshore Inc

424.02M

TURB

Turbo Energy SA

41.20M

OLN

Olin Corp

2.70B

what short term stocks to buy now

Intellectia · 72 candidates

Region: USRsi Category: moderateBeta: LowRisk, ModerateRisk, HighRisk, NegativeBetaList Exchange: XNYS, XNASMoving Average Relationship: PriceAboveMA20Week Price Change Pct: $6.00 - $20.00Monthly Average Dollar Volume: >= 4,000,000

Ticker

Name

Market Cap$

IOT

Samsara Inc

20.40B

CAPR

Capricor Therapeutics Inc

1.52B

UPXI

Upexi Inc

62.78M

Kingsoft Cloud Holdings Ltd

3.62B

WGS

GeneDx Holdings Corp

2.58B

REPL

Replimune Group Inc

666.36M

any good trades for today

Intellectia · 40 candidates

Price: $5.00 - $100.00Volume: >= 1,000,000Price Change Pct: $3.00 - $15.00Relative Vol: >= 1.50List Exchange: XNYS, XNAS, XASEMoving Average Relationship: PriceAboveMA20

Ticker

Name

Market Cap$

DYN

Dyne Therapeutics Inc

2.45B

AXTI

AXT Inc

1.79B

SLDB

Solid Biosciences Inc

525.89M

CAPR

Capricor Therapeutics Inc

1.52B

ICL

ICL Group Ltd

6.38B

TALK

Talkspace Inc

788.52M

what are the best stocks to buy today

Intellectia · 16 candidates

Market Cap: >= 10.00BRegion: USAnalyst Consensus: Strong Buy, Moderate BuyList Exchange: XNYS, XNAS, XASETarget Price Upside Potential: MoreAbovePriceMoving Average Relationship: PriceAboveMA20

Ticker

Name

Market Cap$

NVDA

NVIDIA Corp

4.65T

PDD

PDD Holdings Inc

150.14B

QCOM

Qualcomm Inc

149.82B

SMFG

Sumitomo Mitsui Financial Group, Inc

148.10B

SNY

Sanofi SA

114.04B

CEG

Constellation Energy Corp

106.46B

are there any that are setting up

Intellectia · 67 candidates

Price: $5.00 - $150.00Rsi Category: overbought, oversoldPrice Change Pct: $-50.00 - $-0.30List Exchange: XNYS, XNAS, XASEMonthly Average Dollar Volume: >= 300,000

Ticker

Name

Market Cap$

ATOS

Atossa Therapeutics Inc

72.98M

ANL

Adlai Nortye Ltd

392.25M

YEXT

Yext Inc

878.01M

HOOD

Robinhood Markets Inc

89.45B

XPEV

Xpeng Inc

17.19B

PFSI

PennyMac Financial Services Inc

5.20B

run based on daily

Intellectia · 80 candidates

Ticker

Name

Market Cap$

SPOT

Spotify Technology SA

103.40B

COR

Cencora Inc

68.24B

AFL

Aflac Inc

56.90B

MSCI

MSCI Inc

44.25B

ONC

BeOne Medicines AG

40.49B

Consolidated Edison Inc

37.48B

How about the 3 best under 30 dollars?

Intellectia · 219 candidates

Market Cap: >= 1000.00MPrice: <= $30.00Weekly Average Turnover: >= 1,000,000Pe Ttm: <= 25Annual Revenue Yoy Growth: >= 10.0%

Ticker

Name

Market Cap$

MUFG

Mitsubishi UFJ Financial Group Inc

206.98B

BBVA

Banco Bilbao Vizcaya Argentaria SA

141.76B

IBN

ICICI Bank Ltd

104.54B

RKT

Rocket Companies Inc

59.75B

ABEV

Ambev SA

41.38B

BBD

Banco Bradesco SA

39.45B

Whales Holding XPEV

Ghisallo Capital Management LLC

Shin Kong Investment Trust Co., Ltd.

Lion Global Investors Limited

Tianhong Asset Management Co., Ltd.

Yarbrough Capital, LLC

Trading Trends

People Also Watch

Frequently Asked Questions

What is Xpeng Inc (XPEV) stock price today?

The current price of XPEV is 16.93 USD — it has decreased -3.86

What is Xpeng Inc (XPEV)'s business?

What is the price predicton of XPEV Stock?

Wall Street analysts forecast XPEV stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for XPEV is29.67 USD with a low forecast of 20.00 USD and a high forecast of 50.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

What is Xpeng Inc (XPEV)'s revenue for the last quarter?

Xpeng Inc revenue for the last quarter amounts to 3.14B USD, increased 40.10

What is Xpeng Inc (XPEV)'s earnings per share (EPS) for the last quarter?

Xpeng Inc. EPS for the last quarter amounts to 0.03 USD, decreased -118.75

How many employees does Xpeng Inc (XPEV). have?

Xpeng Inc (XPEV) has 15364 emplpoyees as of March 29 2026.

What is Xpeng Inc (XPEV) market cap?

Today XPEV has the market capitalization of 16.18B USD.

XPEV Overview

XPEV Overview

Events Timeline

News

Valuation Metrics

Forward PE

Forward EV/EBITDA

Forward PS

Financials

Related Community Screener

Whales Holding XPEV

Trading Trends

People Also Watch

Frequently Asked Questions

What is Xpeng Inc (XPEV) stock price today?

What is Xpeng Inc (XPEV)'s business?

What is the price predicton of XPEV Stock?

What is Xpeng Inc (XPEV)'s revenue for the last quarter?

What is Xpeng Inc (XPEV)'s earnings per share (EPS) for the last quarter?

How many employees does Xpeng Inc (XPEV). have?

What is Xpeng Inc (XPEV) market cap?